Patterns of lymph node spread and its influence on outcome in resectable parotid cancer

被引:108
|
作者
Klussmann, J. P. [4 ]
Ponert, T. [4 ]
Mueller, R. P. [3 ]
Dienes, H. P. [2 ]
Guntinas-Lichius, O. [1 ]
机构
[1] Univ Jena, Dept Otorhinolaryngol, D-07740 Jena, Germany
[2] Univ Cologne, Inst Pathol, D-50924 Cologne, Germany
[3] Univ Cologne, Dept Radiat Oncol, D-50924 Cologne, Germany
[4] Univ Cologne, Clin Otorhinolaryngol Head & Neck Surg, D-50924 Cologne, Germany
来源
EJSO | 2008年 / 34卷 / 08期
关键词
carcinoma; salivary gland; locoregional metastasis; treatment results; prognostic factors;
D O I
10.1016/j.ejso.2008.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To assess the metastatic topography of intraparotideal and neck lymph nodes in parotid cancer and its influence on tumour recurrence and survival. Methods: The lymph node spread of 142 patients with primary parotid carcinoma treated from 1986 to 2006 was analysed. Disease-free survival (DFS) and overall survival (OS) were calculated. The role of the metastatic pattern as prognostic factors were univariately and multivariately analysed. Results: A lateral, total or radical parotidectomy was performed in 19, 80 and 43 patients, respectively. A radical/radical-modified or selective neck dissection was performed in 68 and 74 patients, respectively. Eighty-seven neck dissection specimens were negative (pN0). Twelve patients had intraparotideal and cervical lymph node involvement (pPar+/pN+). In 24 patients only intraparotideal metastases were detected (pPar+/pN0). 19 patients only had cervical nodal involvement (pPar-/pN+). Twenty-five patients had occult locoregional lymph metastases (cN0/pN+). The median follow-up was 24.4 months. The disease-free survival rate was 81% at 5 years, and 62% at 10 years. By univariate analysis, R+ (p = 0.001), pT (p = 0.019), lymphangiosis carcinomatosa (p = 0.019), pN+ (p = 0.042), and extracapsular spread (p = 0.046) were prognostic for disease-free survival. Multivariate analysis revealed R+ as independent risk factor (p = 0.046). In pN+ patients, involvement of parotid lymph nodes (p = 0.013), nodes in neck level I (p < 0.0001) and IV (p = 0.005) were univariate risk factors. Multivariate analysis showed lymph node metastases in level I as independent risk factor (p = 0.022). Conclusion: Total parotidectomy and radical-modified neck dissection is recommended as surgical treatment of parotid cancer and should be analysed in a prospective trial. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:932 / 937
页数:6
相关论文
共 50 条
  • [21] Clinicopathological characteristics and treatment outcome of resectable gastric cancer patients with small para-aortic lymph node
    Yao, Zhendan
    Yang, Hong
    Cui, Ming
    Xing, Jiadi
    Zhang, Chenghai
    Zhang, Nan
    Chen, Lei
    Tan, Fei
    Xu, Kai
    Liu, Maoxing
    Su, Xiangqian
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] Patterns of recurrence, treatment, and outcome of lymph node recurrence after SBRT for lung cancer
    Lee, T. H.
    Shin, H.
    Ahn, Y. C.
    Kang, M. K.
    Song, C.
    Kim, W. C.
    Moon, S. H.
    Kim, J. H.
    Cho, J.
    Park, H. J.
    Lee, H. K.
    Kim, B. H.
    Kim, H. J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S814 - S814
  • [23] Lymph node micrometastases and outcome of endometrial cancer
    Ignatov, Atanas
    Lebius, Christin
    Ignatov, Tanja
    Ivros, Stylianos A.
    Knueppel, Robert
    Papathemelis, Thomas
    Ortmann, Olaf
    Eggemann, Holm
    GYNECOLOGIC ONCOLOGY, 2019, 154 (03) : 475 - 479
  • [24] A comparison of competing lymph node staging schemes in resectable biliary cancer
    Smith, D. D.
    Nelson, R. A.
    Schwarz, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] A Comparison Of Competing Lymph Node Staging Schemes In Resectable Gastric Cancer
    Smith, D. D.
    Nelson, R. A.
    Schwarz, R. E.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S64 - S64
  • [26] Nomogram for predicting the preoperative lymph node metastasis in resectable pancreatic cancer
    Cheng, Hao
    Xu, Jin-Hong
    Kang, Xiao-Hong
    Liu, Xiao-Mei
    Wang, Hai-Feng
    Wang, Zhi-Xia
    Pan, Hao-Qi
    Zhang, Qing-Qin
    Xu, Xue-Lian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 12469 - 12477
  • [27] Nomogram for predicting the preoperative lymph node metastasis in resectable pancreatic cancer
    Hao Cheng
    Jin-Hong Xu
    Xiao-Hong Kang
    Xiao-Mei Liu
    Hai-Feng Wang
    Zhi-Xia Wang
    Hao-Qi Pan
    Qing-Qin Zhang
    Xue-Lian Xu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12469 - 12477
  • [28] Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes
    Bohan, Phillip M. Kemp
    O'Shea, Anne E.
    Lee, Andrew J.
    Chick, Robert C.
    Newhook, Timothy E.
    Cao, Hop S. Tran
    Allen, Casey J.
    Nelson, Daniel W.
    Clifton, G. Travis
    Vauthey, Jean-Nicolas
    Tzeng, Ching-Wei D.
    Vreeland, Timothy J.
    SURGICAL ONCOLOGY-OXFORD, 2021, 36 : 138 - 146
  • [29] Clinical significance of intraparotid lymph node metastasis in primary parotid cancer
    Lim, Chwee Ming
    Gilbert, Mark R.
    Johnson, Jonas T.
    Kim, Seungwon
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (11): : 1634 - 1637
  • [30] The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer
    Barry, Peter
    Vatsiou, Alexandra
    Spiteri, Inmaculada
    Nichol, Daniel
    Cresswell, George D.
    Acar, Ahmet
    Trahearn, Nicholas
    Hrebien, Sarah
    Garcia-Murillas, Isaac
    Chkhaidze, Kate
    Ermini, Luca
    Huntingford, Ian Said
    Cottom, Hannah
    Zabaglo, Lila
    Koelble, Konrad
    Khalique, Saira
    Rusby, Jennifer E.
    Muscara, Francesca
    Dowsett, Mitch
    Maley, Carlo C.
    Natrajan, Rachael
    Yuan, Yinyin
    Schiavon, Gaia
    Turner, Nicholas
    Sottoriva, Andrea
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4763 - 4770